Literature DB >> 21317950

[Synthesis and pharmacological activity of amides and ozonolysis product of maleopimaric acid].

O B Kazakova, E V Tret'iakova, O S Kukovinets, G A Tolstikov, T I Nazyrov, I V Chudov, A F Ismagilova.   

Abstract

The synthesis of a new group of maleopimaric acid amides containing fragments of the methyl esters of amino acids, aliphatic amines, imidazole and N-methylpiperazine was carried out. Ozonolysis of methyl maleopimarate flows through the cleavage of double bond C18(19) and the disclosure of anhydrous cycle with formation of secotriacid. As a result of screening of anti-inflammatory and antiulcer activity of maleopimaric acid derivatives new effective compounds such as methyl esters of maleopimaric acid and product of ozonolysis - diterpenic secotriacid, maleopimaric acid amide with L-leucine were revealed. An important advantage of the compounds studied is the low toxicity and the presence of bidirectional activity in the absence of adverse effects on the animal.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21317950

Source DB:  PubMed          Journal:  Bioorg Khim        ISSN: 0132-3423


  4 in total

1.  Synthesis of a multifunctional hard monomer from rosin: the relationship of allyl structure in maleopimarate and UV-curing property.

Authors:  Yanju Lu; Zhendong Zhao; Liangwu Bi; Yuxiang Chen; Jing Wang; Shichao Xu
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

2.  Heterologous production of levopimaric acid in Saccharomyces cerevisiae.

Authors:  Ting Liu; Chuanbo Zhang; Wenyu Lu
Journal:  Microb Cell Fact       Date:  2018-07-18       Impact factor: 5.328

3.  Identifying factors associated with opioid cessation in a biracial sample using machine learning.

Authors:  Jiayi W Cox; Richard M Sherva; Kathryn L Lunetta; Richard Saitz; Mark Kon; Henry R Kranzler; Joel Gelernter; Lindsay A Farrer
Journal:  Explor Med       Date:  2020-02-29

4.  Synthesis, structure, and antitumor activity of 2,9-disubstituted perhydro 2,3a,7b,9,10a,14b-hexaazadibenzotetracenes.

Authors:  Elena B Rakhimova; Victor Yu Kirsanov; Elena V Tret'yakova; Leonard M Khalilov; Askhat G Ibragimov; Lilya U Dzhemileva; Vladimir A D'yakonov; Usein M Dzhemilev
Journal:  RSC Adv       Date:  2020-06-04       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.